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Bronchiolitis obliterans organizing pneumonia (BOOP) is an inflammatory lung disease charac-
terised by polypoid masses of granulation tissue within bronchioles, alveolar ducts and alveoli.
Most commonly BOOP is idiopathic, but it can be induced by a variety of conditions. We report
a case of BOOP in a 37-year-old patient with relapsing pneumonia. The patient has two daugh-
ters with cystic fibrosis and although confirmatory testing was negative, we belief that the
patient has a mild variant of cystic fibrosis. To our knowledge there is only one other case
report describing BOOP in a patient with cystic fibrosis.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
Bronchiolitis obliterans organizing pneumonia (BOOP) is an
inflammatory lung disease and the diagnosis can be chal-
lenging owing to the non-specific symptoms. We present
a case of BOOP in a 37-year-old patient with relapsing
pneumonia. Our patient is remarkable because of the
suspicion of a mild variant of cystic fibrosis.
Case report
A 37-year-old man was referred to our hospital because of
pneumonia of the right upper lobe that did not respond toerstraat, B-2820 Bonheiden,
32 155 17023.
yahoo.com (P. Selleslagh).
ll rights reserved.treatment with IV meropenem. Despite a switch in anti-
microbial treatment to piperacillineetazobactam and
subsequently to cefepime there was no clinical or
biochemical improvement. Sputum cultures and bronchial
aspirates could not identify a responsible bacteria.
The patient’s medical history was remarkable for
‘‘chronic bronchitis’’ during childhood and a progressive
chronic renal failure due to nephroangiosclerosis requiring
hemodialysis since the age of 36. In the past three years he
developed five consecutive pneumonias in both lungs.
Sputum cultures taken during these different episodes
identified the following pathogens: Pseudomonas aerugi-
nosa, Burkholderia cepacia, Moraxella catarrhalis and
Aspergillus fumigatus. Although treatment with culture
guided broad-spectrum antibiotics proved successful each
time, the patient relapsed after a few months. Four months
before admission treatment with voriconazole was started
because of growth of A. fumigatus in a bronchial aspirate
Figure 2 Spiral computed tomography scan of the chest
shows consolidation with an air bronchogram in the lateral
segment of the right upper lobe and surrounding ground glass
opacities. There is an important destruction of the left lung
parenchyma with cavities and bronchiectasis.
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on a computed tomography (CT) scan of the thorax.
Family history revealed two daughters with cystic
fibrosis and although a F508 mutation of the CFTR gene was
demonstrated in the patient, a sweat test was repeatedly
negative. The patient had smoked one pack of cigarettes
a day for 20 years, but smoking cessation was achieved two
years ago. There were no known allergies and no exposure
to toxic substances.
Onadmission, his temperaturewas38.5 C,bloodpressure
120/66 mmHg, pulse rate 110/min and regular, respiratory
frequency 20 breaths per minute and the oxygen saturation
98%. Lung auscultation revealed bilateral ronchi, cardiac and
abdominal examination were normal and no lymphadenop-
athy was found. Laboratory studies revealed a C-reactive
proteinof 133 mg/L, awhitebloodcountof 15,000/Lwith79%
neutrophils, chronic renal failure (urea 43 mg/dL, creatinine
3.0 mg/dL) and cholestatic liver function tests (aspartate
transaminase 45 U/L, alanine transaminase 25 U/L, alkaline
phosphatase 1568 U/L, Gamma glutamyl transpeptidase
987 U/L, lactate dehydrogenase 287 U/L). Chest radiog-
raphy (Fig. 1) demonstrated a consolidation in the base of
the right upper lobe. Both lungs showed extensive signs
of chronic bronchial disease (bronchial wall thickening,
bronchiectasis, peribronchial infiltration) and signs of lung
destruction. A CT scan of the thorax (Fig. 2) showed
consolidation with an air bronchogram in the lateral
segment of the right upper lobe and surrounding ground
glass opacities. On the fifth hospital day a transthoracic
puncture biopsy was performed of the consolidation in
the right upper lobe. Microscopy (Fig. 3) demonstrated
granulation tissue and fibroblastic proliferation within
bronchioles, alveolar ducts and alveoli, associated with
a mononuclear interstitial infiltrate. There were no signs of
infection or fungi. The diagnosis of Bronchiolitis obliterans
organizing pneumonia (BOOP) was made. Antibiotics wereFigure 1 A supine posteroanterior chest radiography
demonstrates a consolidation in the base of the right upper
lobe. Both lungs show signs of chronic bronchial disease and lung
destruction. At the left lung apex there is pleural thickening.
A Hickmann catheter is present in the right subclavian vein.stopped and treatment with intravenous methylpredniso-
lone 40 mg once daily was started with rapid clinical and
biochemical improvement within 48 h. At 1 month of follow-
up there is no relapse and the dose of methylprednisolone is
slowly being tapered. The patient is a candidate for
a combined renal-lung transplantation. Although confirma-
tory testing was negative, there remains a high suspicion of
underlying cystic fibrosis.
Discussion
Bronchiolitis obliterans organizing pneumonia is an inflam-
matory lung disease characterised by polypoid masses of
granulation tissue within bronchioles, alveolar ducts and
alveoli.1Figure 3 Transthoracic puncture biopsy stained with hema-
toxylineeosin demonstrates granulation tissue and fibroblastic
proliferation within bronchioles, alveolar ducts and alveoli,
associated with a mononuclear interstitial infiltrate.
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by a variety of conditions. BOOP can develop after an
infectious pneumonia with bacteria (Chlamydia, Legion-
ella, Mycoplasma pneumoniae, P. aeruginosa), viruses
(parainfluenza virus, adenovirus) and fungi (Cryptococcus
neoformans, Pneumocystis jiroveci).2,3 Drug-related BOOP
has been associated with the use of immunosuppressive
agents including bleomycin, gold, methotrexate and anti-
biotics such as sulfasalazine, cephalosporins, amphotericin
B and a few other drugs like amiodarone, phenytoin, car-
bamazepine, ticlopidine and cocaine.2 BOOP can be
secondary to virtually every rheumatologic or connective
tissue disease. It has also been described after bone
marrow, lung and renal transplantation.2 Radiotherapy to
the breast is also believed to prime the development of
BOOP.4 Finally there are reports of BOOP in association with
a wide diversity of diseases like lymphoma, inflammatory
bowel disease, alcoholic cirrhosis, cystic fibrosis and
others.2,5
Classically BOOP presents as a flu-like illness with fever,
cough and dyspnea. Lung auscultation usually reveals
crackles and blood results generally show inflammation.
Pulmonary function is characterised by a mild to moderate
decrease in vital capacity and diffusion capacity.2
In rare cases the disease can progress rapidly resulting in
respiratory failure within a few days.6
The chest radiograph typically shows bilateral patchy
infiltrates that can be migratory, but there are case reports
of unilateral disease as well.7,8 Computed tomography of
the chest demonstrates bilateral areas of consolidation and
ground glass opacities, usually located peripherally.
Sometimes nodular lesions can be present, resembling
bronchial carcinoma or pulmonary metastases.9,10
The diagnosis of BOOP can be challenging owing to the
non-specific symptoms and therefore lung biopsy is the
preferred method of diagnosis. The standard treatment is
prednisone 60 mg a day for 1e3 months, followed by 40 mg
a day for 3 months and finally 10e20 mg a day for a total of
1 year.2 Total recovery is seen in most patients, but one
third might relapse, in which case treatment with cortico-
steroids is restarted.1 In case of refractory disease to
prednisone, one must consider an underlying fibrotic lung
disease such as usual interstitial pneumonia (UIP) and
idiopathic pulmonary fibrosis (IPF).We suspect that in our patient the BOOP was secondary
to a pneumonia with P. aeruginosa. Additionally, we belief
that the patient has a mild variant of cystic fibrosis as he
was found to be heterozygote for the most common CFTR
gene mutation (F508), although a sweat test was repeat-
edly negative. To our knowledge there is only one other
case report describing BOOP in a patient with cystic
fibrosis.5
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